Medical cost of acute diarrhea in children in ambulatory care
Xavier Sánchez1, Gerardine Leal2, Angel Padilla2
1Centro de Investigación en Salud para América Latina (CISeAL), Facultad de Medicina, Pontificia Universidad Católica del Ecuador (PUCE), Quito, Ecuador.
Insights
The direct medical cost of acute diarrhea in children under five in Ecuador was $45.24 per episode. Unnecessary lab tests significantly increased the total annual cost for the Ministry of Public Health.
Area of Science:
- Health Economics
- Pediatric Infectious Diseases
- Public Health Policy
Background:
- Acute diarrhea (AD) poses a significant health burden on young children globally.
- Estimating the direct medical costs of AD is crucial for resource allocation in healthcare systems.
Purpose of the Study:
- To determine the direct medical cost per episode and annual cost of acute diarrhea in children under five.
- To analyze costs within Ecuador's Ministry of Public Health (MOPH) ambulatory care centers.
Main Methods:
- A cost of illness study using micro-costing from a provider perspective.
- Valuation of health resources in international dollars using MOPH tariffs and pharmacy purchase data.
Main Results:
- Analysis included 332 electronic health records of children under five.
- Mean cost per episode of AD was $45.24 (2019 USD).
- Total estimated annual cost for MOPH in 2019 was over $6.6 million.
Conclusions:
- Direct medical costs for acute diarrhea in young children are substantial.
- A significant portion of AD costs in outpatient settings is attributed to potentially unnecessary laboratory tests.
Objective:
The aim of this study was to estimate the direct medical cost per episode and the annual cost for acute diarrhea (AD) in children under five years of age in Ambulatory Care Centers of the Ministry of Public Health (MOPH) of Ecuador.
Methods:
A cost of illness study with a provider perspective was carried out through a micro-costing of health resources and valuated in international dollars. Medical consultations and laboratory tests were valued using the tariff framework of services for the National Health System and for the prescribed medications, a reported cost registry of pharmacy purchases made in the year of study was used.
Results:
A total of 332 electronic health records of children under five years of age were included in the analysis. Laboratory tests were performed on 37.95% (126/332), medications were prescribed to 93.67% (311/332) of the children, and antimicrobials were prescribed to 37.35% (124/332) of the children, representing an antibiotic prescription rate of 26.51% (88/332) and an antiparasitic prescription rate of 10.84% (36/332). The mean cost of the MOPH per child per episode of AD was US$45.24 (2019 dollars) (95% CI:43.71 to 46.76).
Conclusion:
The total estimated cost of AD in children under five years of age for the MOPH in 2019 was about US$6,645,167.88 million (2019 dollars) (95% CI: 6,420,430.77 to 6,868,436.12). A high proportion of the direct medical cost of AD in children under five years of age in outpatient settings is due to unnecessary laboratory tests.
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Acute Kidney Injury V: Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Acute Pancreatitis II: Clinical Manifestations and Management


